Skip to main content

Efficient Production of Cytovene®

New synthetic methodology for ganciclovir, the main active component in Cytovene®. The conventional production process of ganciclovir was very wasteful and involved environmentally hazardous chemicals. CordenPharma Colorado developed the Guanine Triester (GTE) Process, a new method that climates the production of hazardous solid waste. This novel process introduces a recycling process of total recovery for 80% of inputs. The overall process is also more cost-efficient as it requires less monitoring and transportation of hazardous chemicals.

EPA Presidential Green Chemistry Challenge: 2000 Greener Synthetic Pathways Award

Inventor/Owner/Manufacturer/Supplier
Corden Pharma Colorado
Category
Image
CordenPharma_logo